Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Hangzhou 42 Hanzhou 6 Zhengzhou 3 Huzhou 2 Lishui 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University101 First Affiliated Hospital of Zhejiang University100 AstraZeneca74 Zhejiang Cancer Hospital65 Clear sponsor filter
Site location
Hangzhou42 Hanzhou6 Zhengzhou3 Huzhou2 Lishui2
All 26 locations
Target enrolment
to

Trials with a site in Hangzhou

42 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Not yet open
Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
NCT07920133Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk
DrugColchicine
Sir Run Run Shaw Hospital
Not applicable
1,768
Hangzhou
2026-12-01
Not yet open
Sir Run Run Shaw Hospital
Not applicable
106
Hangzhou
2026-11-01
Not yet open
Sir Run Run Shaw Hospital
Not applicable
120
Hangzhou
2026-11-01
Recruiting
Sir Run Run Shaw Hospital
Observational
3,000
Hangzhou
2026-11
Recruiting
Electroacupuncture at ST36 for Reducing Postoperative Inflammation After Cardiac Surgery With Cardiopulmonary Bypass
NCT07795112Systemic Inflammatory Response Syndrome (SIRS), Cardiac Surgical Procedures, Postoperative Complications (Cardiopulmonary)
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2026-09-01
Not yet open
PTSD Risk Prediction Model for EICU Survivors
NCT07747415Post-traumatic Stress Disorder (PTSD)
Sir Run Run Shaw Hospital
Observational
800
Hangzhou
2026-08-15
Not yet open
Sir Run Run Shaw Hospital
Not applicable
212
Hangzhou
2026-07-01
Recruiting
Sir Run Run Shaw Hospital
Not applicable
190
Binzhou, Hangzhou
2026-06-14
Not yet open
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2026-06
By invitation
Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk
NCT07453940ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, PFA Ablation and LAAC Procedures
Sir Run Run Shaw Hospital
Not applicable
50
Hangzhou
2026-05-07
Recruiting
Sir Run Run Shaw Hospital
Not applicable
152
Hangzhou
2026-04-27
Active, closed
Sir Run Run Shaw Hospital
Not applicable
312
Hangzhou
2026-03-20
Not yet open
Decision-making and Optimization of Ventilatory Support for AECOPD Patients
NCT07508943Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Sir Run Run Shaw Hospital
Observational
1,000
Hangzhou
2026-03-18
Recruiting
Sir Run Run Shaw Hospital
Not applicable
600
Hangzhou
2026-03-17
Active, closed
Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer
NCT07512674Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis
Sir Run Run Shaw Hospital
Phase 2
33
Hangzhou
2026-02-26
Active, closed
AI-Powered Sound Analysis for COPD Screening
NCT07457073Chronic Obstructive Pulmonary Disease (COPD)
Sir Run Run Shaw Hospital
Observational
3,000
Hangzhou
2026-02-23
Recruiting
Sir Run Run Shaw Hospital
Phase 4
846
Hangzhou, Huzhou, Ningbo
2026-02-09
Not yet open
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07393477Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2026-02
Recruiting
Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
NCT07268560Complicated Intra-Abdominal Infections, cIAIs, Hospital-acquired Pneumonia (HAP), Ventilator-Associated Pneumonia (VAP)
DrugAztreonam-Avibactam
Sir Run Run Shaw Hospital
Observational
100
Nanchang, Hangzhou
2025-12-25
Recruiting
Sir Run Run Shaw Hospital
Not applicable
33
Hangzhou
2025-12-01
Recruiting
Sir Run Run Shaw Hospital
Phase 2
52
Hangzhou
2025-10-09
Active, closed
Sir Run Run Shaw Hospital
Not applicable
5
Hangzhou
2025-09-01
Active, closed
Sir Run Run Shaw Hospital
Phase 2
29
Hangzhou
2025-08-20
Recruiting
Sir Run Run Shaw Hospital
Phase 2
59
Hangzhou
2025-07-03
Recruiting
Effectiveness of DITM Versus IMT in COPD Patients
NCT06958666COPD (Chronic Obstructive Pulmonary Disease)
Sir Run Run Shaw Hospital
Not applicable
410
Hangzhou, Lishui, Taizhou
2025-06-30
Recruiting
Sir Run Run Shaw Hospital
Not applicable
100
Hangzhou
2025-06-01
Recruiting
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2025-06
By invitation
Sir Run Run Shaw Hospital
Not applicable
724
Hangzhou
2025-04-22
Recruiting
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Not yet open
Sir Run Run Shaw Hospital
Phase 2
33
Hangzhou
2025-04-01
Not yet open
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Recruiting
Sir Run Run Shaw Hospital
Not applicable
2,000
Hangzhou
2024-10-09
Not yet open
Sir Run Run Shaw Hospital
Phase 2
80
Hangzhou
2024-10
Recruiting
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2024-01-01
Recruiting
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Sir Run Run Shaw Hospital
Not applicable
422
Hangzhou, Huzhou, Jinhua, Lishui, Ningbo, Quzhou, Shaoxing, Taizhou
2023-07-01
Recruiting
Sir Run Run Shaw Hospital
Phase 3
108
Hangzhou
2023-04-01
Recruiting
Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion
NCT06633809Stroke, Acute, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases
Sir Run Run Shaw Hospital
Observational
200
Hangzhou
2021-11-22
Recruiting
Sir Run Run Shaw Hospital
Early Phase 1
10
Hangzhou
2021-09-05
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

23 of the 42 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 12 have not yet opened recruitment, 5 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 42 studies
PhaseStudiesRecruitingShare
Not applicable201047.6%
Phase 210423.8%
Observational6314.3%
Phase 1337.1%
Early Phase 1112.4%
Phase 3112.4%
Phase 4112.4%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Sir Run Run Shaw Hospital4223
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.